MICHELLE CRAVER: Open Payments
NPI 1336893999 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 37 payments from 10 companies in 2025. Trend: 2023 $1,533 · 2024 $1,052 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $206 |
| Alnylam Pharmaceuticals Inc. | 8 | $166 |
| PFIZER INC. | 5 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $83 |
| E.R. Squibb & Sons, L.L.C. | 2 | $54 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $18 |
| Amgen Inc. | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $11 |
Products named: LEQVIO, ONPATTRO, JARDIANCE, VYNDAQEL, AMVUTTRA, CAMZYOS, ELIQUIS, Attruby.
Industry payments across TX — which companies pay providers there.
